Search
for
Sort by
Research 151–180 of 723
- 3D printed microneedles: revamping transdermal drug delivery systems
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Hair loss and herbs for treatment
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Anabolic-androgenic steroids and cardiovascular risk
- Side effects of common acne treatments
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Skin disease in pregnancy
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Polycystic ovary syndrome: A review for dermatologists
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Endocrine evaluation of hirsutism
- Finasteride Treatment of Hair Loss in Women
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Clinical applications of antiandrogens
- Recent advances in the treatment of psoriasis
- Gender-Affirming Hormone Therapy for Transgender Men
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Effect of finasteride in idiopathic hirsutism
- Idiopathic CD4+ T-lymphocytopenia
- Hirsutism: diagnosis and treatment
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Interventions for morphea
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases